Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody

B. Dietzschold, M. Tollis, C. E. Rupprecht, Esteban Celis, H. Koprowski

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Immunization experiments with vaccines prepared from the PM and ERA strains of rabies virus demonstrated that in mice, only ERA vaccine primes for an anamnestic response to the rabies-related strain Duvenhage (DUV6); in rabbits, both ERA and PM vaccines induced immunologic memory to DUV6 virus. In mice, ERA vaccine, but not an equal concentration of PM vaccine, conferred protection against a lethal challenge infection with DUV6 virus. This result indicated that the protective activity correlated with the vaccine's ability to induce immunologic memory. A vaccine prepared from a sequentially selected neutralization-resistant, multiple-variant virus conferred protection against challenge with the parental strain, a result indicating that antigenic variation of the glycoprotein may not be the sole factor in determining the relative efficacy of rabies prophylaxis. We found no correlation between titers of neutralizing antibody and mortality rates in mice immunized with purified glycoprotein from these viruses.

Original languageEnglish (US)
Pages (from-to)815-822
Number of pages8
JournalJournal of Infectious Diseases
Volume156
Issue number5
DOIs
StatePublished - Jan 1 1987
Externally publishedYes

Fingerprint

Cross Protection
Antigenic Variation
Rabies virus
Rabies
Neutralizing Antibodies
Glycoproteins
Vaccines
Viruses
Immunologic Memory
Immunization
Rabbits
Mortality
Infection

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Antigenic variation in rabies and rabies-related viruses : cross-protection independent of glycoprotein-mediated virus-neutralizing antibody. / Dietzschold, B.; Tollis, M.; Rupprecht, C. E.; Celis, Esteban; Koprowski, H.

In: Journal of Infectious Diseases, Vol. 156, No. 5, 01.01.1987, p. 815-822.

Research output: Contribution to journalArticle

@article{0fbc2e98c7424611922a58941c2f2cef,
title = "Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody",
abstract = "Immunization experiments with vaccines prepared from the PM and ERA strains of rabies virus demonstrated that in mice, only ERA vaccine primes for an anamnestic response to the rabies-related strain Duvenhage (DUV6); in rabbits, both ERA and PM vaccines induced immunologic memory to DUV6 virus. In mice, ERA vaccine, but not an equal concentration of PM vaccine, conferred protection against a lethal challenge infection with DUV6 virus. This result indicated that the protective activity correlated with the vaccine's ability to induce immunologic memory. A vaccine prepared from a sequentially selected neutralization-resistant, multiple-variant virus conferred protection against challenge with the parental strain, a result indicating that antigenic variation of the glycoprotein may not be the sole factor in determining the relative efficacy of rabies prophylaxis. We found no correlation between titers of neutralizing antibody and mortality rates in mice immunized with purified glycoprotein from these viruses.",
author = "B. Dietzschold and M. Tollis and Rupprecht, {C. E.} and Esteban Celis and H. Koprowski",
year = "1987",
month = "1",
day = "1",
doi = "10.1093/infdis/156.5.815",
language = "English (US)",
volume = "156",
pages = "815--822",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Antigenic variation in rabies and rabies-related viruses

T2 - cross-protection independent of glycoprotein-mediated virus-neutralizing antibody

AU - Dietzschold, B.

AU - Tollis, M.

AU - Rupprecht, C. E.

AU - Celis, Esteban

AU - Koprowski, H.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Immunization experiments with vaccines prepared from the PM and ERA strains of rabies virus demonstrated that in mice, only ERA vaccine primes for an anamnestic response to the rabies-related strain Duvenhage (DUV6); in rabbits, both ERA and PM vaccines induced immunologic memory to DUV6 virus. In mice, ERA vaccine, but not an equal concentration of PM vaccine, conferred protection against a lethal challenge infection with DUV6 virus. This result indicated that the protective activity correlated with the vaccine's ability to induce immunologic memory. A vaccine prepared from a sequentially selected neutralization-resistant, multiple-variant virus conferred protection against challenge with the parental strain, a result indicating that antigenic variation of the glycoprotein may not be the sole factor in determining the relative efficacy of rabies prophylaxis. We found no correlation between titers of neutralizing antibody and mortality rates in mice immunized with purified glycoprotein from these viruses.

AB - Immunization experiments with vaccines prepared from the PM and ERA strains of rabies virus demonstrated that in mice, only ERA vaccine primes for an anamnestic response to the rabies-related strain Duvenhage (DUV6); in rabbits, both ERA and PM vaccines induced immunologic memory to DUV6 virus. In mice, ERA vaccine, but not an equal concentration of PM vaccine, conferred protection against a lethal challenge infection with DUV6 virus. This result indicated that the protective activity correlated with the vaccine's ability to induce immunologic memory. A vaccine prepared from a sequentially selected neutralization-resistant, multiple-variant virus conferred protection against challenge with the parental strain, a result indicating that antigenic variation of the glycoprotein may not be the sole factor in determining the relative efficacy of rabies prophylaxis. We found no correlation between titers of neutralizing antibody and mortality rates in mice immunized with purified glycoprotein from these viruses.

UR - http://www.scopus.com/inward/record.url?scp=0023629286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023629286&partnerID=8YFLogxK

U2 - 10.1093/infdis/156.5.815

DO - 10.1093/infdis/156.5.815

M3 - Article

C2 - 3655404

AN - SCOPUS:0023629286

VL - 156

SP - 815

EP - 822

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -